TotalMarketCap

CytoMed Therapeutics

GDTCNasdaq SingaporeHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.408 M

$0.88 +0.14%

Close of 6 Nov 2026

As of 6 Nov 2026, CytoMed Therapeutics (GDTC) has a market capitalization of $10.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

11,828,435

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #411Palatin TechnologiesPTN$10.5M
  2. #412BiovieBIVI$10.5M
  3. #413CytoMed TherapeuticsGDTC$10.4M
  4. #414Chemomab TherapeuticsCMMB$10.3M
  5. #415Azora Therapeutics, Inc. (DE)AZR$10.0M

What if CytoMed Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,387,203

Per share 2,713,039× higher

Bitcoin $1.53T

$129,167.39

Per share 146,798× higher

Apple $5.02T

$424,044.48

Per share 481,923× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for CytoMed Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.